Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Actinogen Medical ( (AU:ACW) ) is now available.
Actinogen Medical Limited announced the cessation of 1,600,000 securities due to the expiry of options or other convertible securities without exercise or conversion. This development may impact the company’s capital structure and could influence investor perceptions regarding its financial strategies and future prospects.
More about Actinogen Medical
Actinogen Medical Limited operates in the biotechnology industry, focusing on developing innovative therapies for cognitive impairment and neurodegenerative diseases. The company is primarily engaged in research and development of treatments that target neurological conditions, aiming to address significant unmet medical needs in this sector.
YTD Price Performance: 28.00%
Average Trading Volume: 2,942,808
Technical Sentiment Signal: Hold
Current Market Cap: A$101.6M
For a thorough assessment of ACW stock, go to TipRanks’ Stock Analysis page.